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The phenomenon of uniparental gene expression is termed "genomic imprinting,"
which appears to be controlled by epigenetic DNA base modifications (reviewed in refs 3, 4) or chromatin structure alterations (reviewed in ref 5). Genomic imprinting is known to play a critical role in the developing mammalian embryo because zygotes having genes derived from a single parent fail to develop normally (6);itsimportance in carcinogenesisis also now becoming evident. In this review the role of imprinted genes in carcinogenesis, particularly in liver carcinogenesis, will be discussed. For the purpose of this review an imprinted gene will be one where the parental alleles are differentially expressed, and an imprint or imprinting mark will refer to an epigenetic signal that distinguishes between the parental alleles (e.g., DNA base methylation).
WHY ARE GENES IMPRINTED?
To date, a number of imprinted genes have been identified (Table 1 ). The importance of these genes to embryonic development and survival is evident from studies with dipbid embryos containingeithertwo paternalgenomes (androgenotes)or two maternal genomes (gynogenotes),and with mice in which both copies ofa particular chromosome are inheritedfrom one parent (20, 21 X inactivatii)n center.
NR, not re- In mammals, the M6PJIGF2R possesses distinct binding regions for both phosphomannosyl residues and IGF2. Repeats 3 and 9 of the receptor are necessary for the binding The FASEB Journal DE SOUZA ET AL.
tration 
M6P/IGF2R
AND HEPATOCARCINOGENESIS
One of the earliest experimental indications of the potential involvement of the M6pIIgf2r gene in tumor formation came from rat liver carcinogenesis studies (108). A small subset of diethylnitrosamine-induced preneoplastic liver lesions were found not to immunohistochemically stain for the M6p/Igf2r, and a majority of the HCCs were either partially or uniformly negative for this receptor. These findingsdemonstrated that loss of the M6p/Igf2r could occur earlyin liver carcinogenesis, and suggested the interesting possibility that those preneoplastic lesions that lack the M6p/Igf2r preferentially progress to carcinomas. Additional evidence supporting a role for the M6pIIgf2r incarcinogenesis comes from an investigation with the monoterpene, d-limonene (109). The steady-stateM6p/ Igf2r mRNA level
SUMMARY AND CONCLUSIONS
Imprinted genes have clearlybeen shown to play an important role in carcinogenesis.
The paternally imprinted
IGF2
gene is involved in a multitude of different tumor types, including HCCs, and one mechanism by which expression of this oncogenic growth factor is deregulated is through the lossof genomic imprinting. Recently,we provided genetic evidencethatanotherimprintedgene,theM6P/IGF2R, functionsas a tumor suppressor in both liver and breast tumors.
Loss of the M6P/IGF2R gene is an early event in carcinogenesis and occurs in both human and rodent liver tumors.
The M6P/IGF2R gene is imprintedin mice, but imprinting appears to be a polymorphic trait in humans, with the majority of individuals not being imprinted at this locus. The existence of a subset of people in whom the M6P/IGF2R
gene is imprinted must be confirmed since they would be expected to be genetically predisposed to tumor formation. The marked speciesdifference in the imprintedstatusof the M6P/IGF2R gene may also provide a novel genetic explanation of why mice have an increased susceptibility to tumor formation.
The most appropriate way to factor such species differences in genomic imprinting into human risk assessment models must now be addressed. Peamall, R. S., Shibata, H., Bmzowska, A.. Yoshino. K., Okuda, K., dejong, P. J., Plass, C., Chapman, V. 
